173 related articles for article (PubMed ID: 33764665)
1. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
[TBL] [Abstract][Full Text] [Related]
2. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
3. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Naitoh A; Aoyagi Y; Asakura H
J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
[TBL] [Abstract][Full Text] [Related]
4. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of revisited fucosylated alpha-fetoprotein (AFP-L3) with an autoanalyzer μTAS in a clinical laboratory.
Choi J; Park Y; Kim JH; Kim HS
Clin Chim Acta; 2012 Jan; 413(1-2):170-4. PubMed ID: 21946051
[TBL] [Abstract][Full Text] [Related]
6. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Mita Y; Aoyagi Y; Suda T; Asakura H
J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
[TBL] [Abstract][Full Text] [Related]
7. Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Tamura Y; Igarashi M; Kawai H; Suda T; Satomura S; Aoyagi Y
Dig Dis Sci; 2010 Dec; 55(12):3576-83. PubMed ID: 20407827
[TBL] [Abstract][Full Text] [Related]
8. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
[TBL] [Abstract][Full Text] [Related]
9. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
[TBL] [Abstract][Full Text] [Related]
10. Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.
Wu M; Liu Z; Zhang A; Li N
Int J Biol Markers; 2019 Mar; 34(1):20-26. PubMed ID: 30854929
[TBL] [Abstract][Full Text] [Related]
11. PRM-MS Quantitative Analysis of Isomeric
Gutierrez Reyes CD; Huang Y; Atashi M; Zhang J; Zhu J; Liu S; Parikh ND; Singal AG; Dai J; Lubman DM; Mechref Y
Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436504
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
[TBL] [Abstract][Full Text] [Related]
13. Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.
Tamura Y; Suda T; Arii S; Sata M; Moriyasu F; Imamura H; Kawasaki S; Izumi N; Takayama T; Kokudo N; Yamamoto M; Iijima H; Aoyagi Y
Dig Dis Sci; 2013 Aug; 58(8):2406-12. PubMed ID: 23595518
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
15. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
18. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
19. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
Aoyagi Y; Suzuki Y; Isemura M; Nomoto M; Sekine C; Igarashi K; Ichida F
Cancer; 1988 Feb; 61(4):769-74. PubMed ID: 2448024
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
